{
  "docId": "019dd923-5eff-723e-9be8-93d1dbdd7460",
  "docSlug": "2YVCdgm7fPZeOSnMpFY4",
  "documentTitle": "Here's an exclusive look at the 21-slide pitch deck that psychedelics-education platform Fluence used to raise $3 million from top psychedelics VCs",
  "authorId": "Pitchdecks",
  "authorName": "Fluence",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 7,
  "pageCount": 21,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses media logos and headlines as social proof to establish market timing.",
  "elementsJson": [
    "action_title",
    "bullet_list",
    "quote_block"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5eff-723e-9be8-93d1dbdd7460/7",
  "deckHref": "/decks/019dd923-5eff-723e-9be8-93d1dbdd7460",
  "deckJsonHref": "/decks/019dd923-5eff-723e-9be8-93d1dbdd7460.json",
  "deckAnchorHref": "/decks/019dd923-5eff-723e-9be8-93d1dbdd7460#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.1,
        "x": 0.78,
        "y": 0.65
      },
      "kind": "image",
      "text": "Forbes",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "10566c25-bab1-435a-bc07-27074785c3ad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.05,
        "x": 0.6,
        "y": 0.4
      },
      "kind": "image",
      "text": "CNBC",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1f75c856-458a-4980-921b-924da8c95ba9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.15,
        "x": 0.78,
        "y": 0.3
      },
      "kind": "image",
      "text": "The New York Times",
      "attrs": null,
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8de37449-0ef6-4fc9-95f9-286c291e1b12",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.4,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "list",
      "text": "Johns Hopkins, Yale, University of California, Berkley, Mount Sinai, and NYU have recently established psychedelic research centers\n\nPsychedelic psychotherapy legalization initiatives are in motion across the United States, Canada and parts of Europe\n\nFDA grants \"breakthrough therapy\" status to psilocybin therapy for its potential to combat severe treatment-resistant depression\n\nFirst Phase 3 clinical trial conducted with psychedelic-assisted therapy found that MDMA paired with counseling brought marked relief to patients with severe post-traumatic stress disorder",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d08c9c8-542f-4f45-b484-3caaa66f7dc5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.5,
        "y": 0.5
      },
      "kind": "paragraph",
      "text": "A psychedelic drug boom in mental health treatment comes closer to reality",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "13830957-55f4-4b4c-bd57-431a58139215",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.78,
        "y": 0.7
      },
      "kind": "paragraph",
      "text": "Why The Future Of Mental Health Care May Lie In Psychedelics",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "70f65ea0-c7be-471a-b40a-6907b9836fd0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.78,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "The Psychedelic Revolution Is Coming. Psychiatry May Never Be The Same.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "85060bb7-1ef6-43cc-8ceb-40496b95b3ff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "The Psychedelic Revolution Is Coming. Psychiatry May Never Be The Same. (The New York Times)",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd952-9437-76cb-b83e-c5e953d9d931",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.55,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "GAINING ACCEPTANCE OF PSYCHEDELIC DRUGS FOR TREATING MENTAL HEALTH DISORDERS",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d46dae14-0b57-4918-bdd0-203c68fa5563",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "authority-citation",
      "slug": null,
      "matchId": "f0797538-913e-40a4-81c2-a75def54deaf",
      "evidence": "Uses major media outlets and academic institutions to validate the trend.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 6,
      "beatId": "2c055ad5-fd17-4cdf-a5f7-c70fabf95cc8",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Agitate",
      "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
      "evidence": "The deck agitates the problem by highlighting the limitations of current approaches to treating mental illness and the growing acceptance of psychedelic drugs",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Development",
      "parentBeatSlug": "development"
    }
  ],
  "loops": [
    {
      "to": 7,
      "from": 5,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "e1babb95-45fa-46a4-bbea-d3301b873e87",
      "evidence": "The deck highlights the growing mental health crisis and the limitations of current approaches to treating mental illness",
      "position": 0,
      "objective": "What is the cost of not addressing the mental health crisis effectively?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 7,
      "from": 6,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "2ce2cb36-532c-4da1-b164-2590024ed848",
      "evidence": "The deck highlights the growing acceptance of psychedelic drugs for treating mental health disorders",
      "position": 2,
      "objective": "Why is now the right time for psychedelic medicine?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}